McKinsey vet Dewhurst joins Lightrock
Plus: Wugen appoints Alles as chair and updates from Cerevel, Ribbon, Immodulon and more
Martin Dewhurst announced on LinkedIn that he has joined Lightrock, a London-based global impact investor. Dewhurst established and co-led the McKinsey Health Institute, and worked at the consulting company for over 30 years.
NK and CAR T cell company Wugen Inc. appointed Mark Alles to succeed Natalie Mount as chair. Alles was chairman and CEO at Celgene Corp., and has served on the boards of Turning Point Therapeutics Inc., PhRMA, the European Federation of Pharmaceutical Industries and Associations (EFPIA) and BIO. Mount will become a director. ...